• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lipid-Modified Aminoglycosides for mRNA Delivery to the Liver.用于将mRNA递送至肝脏的脂质修饰氨基糖苷类药物。
Adv Healthc Mater. 2020 Apr;9(7):e1901487. doi: 10.1002/adhm.201901487. Epub 2020 Feb 28.
2
Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.通过功能化脂质纳米颗粒传递的 mRNA 成功重编程细胞蛋白生产。
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3351-E3360. doi: 10.1073/pnas.1720542115. Epub 2018 Mar 27.
3
Chemistry of Lipid Nanoparticles for RNA Delivery.脂质纳米颗粒的 RNA 递送化学。
Acc Chem Res. 2022 Jan 4;55(1):2-12. doi: 10.1021/acs.accounts.1c00544. Epub 2021 Dec 1.
4
Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.可离子化脂质纳米颗粒包封条码化 mRNA 用于加速体内递药筛选
J Control Release. 2019 Dec 28;316:404-417. doi: 10.1016/j.jconrel.2019.10.028. Epub 2019 Oct 31.
5
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.用于细胞内 mRNA 递送和基因组编辑的可生物降解脂质纳米粒子的开发。
Acc Chem Res. 2021 Nov 2;54(21):4001-4011. doi: 10.1021/acs.accounts.1c00500. Epub 2021 Oct 20.
6
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis.合成脂质纳米粒肺选择性 mRNA 递送来治疗肺淋巴管肌瘤病。
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8). doi: 10.1073/pnas.2116271119.
7
A Nanoprimer To Improve the Systemic Delivery of siRNA and mRNA.一种用于提高 siRNA 和 mRNA 系统递送的纳米引物。
Nano Lett. 2020 Jun 10;20(6):4264-4269. doi: 10.1021/acs.nanolett.0c00752. Epub 2020 May 6.
8
Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics.脂质纳米粒在核酸、mRNA 及基于基因编辑的治疗药物传递中的最新进展。
Drug Metab Pharmacokinet. 2022 Jun;44:100450. doi: 10.1016/j.dmpk.2022.100450. Epub 2022 Feb 5.
9
One-Component Cationic Lipids for Systemic mRNA Delivery to Splenic T Cells.用于全身 mRNA 递送至脾 T 细胞的单一组分阳离子脂质体。
Angew Chem Int Ed Engl. 2024 Jun 21;63(26):e202405444. doi: 10.1002/anie.202405444. Epub 2024 May 21.
10
Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.用于优化基于 RNA 的经皮递送至小鼠气道的脂质纳米颗粒制剂。
Eur J Pharm Sci. 2022 Sep 1;176:106234. doi: 10.1016/j.ejps.2022.106234. Epub 2022 Jun 8.

引用本文的文献

1
Developing the Strategy to Use Silk Spheres for Efficient, Targeted Delivery of Oligonucleotide Therapeutics to Cancer Cells.制定使用丝球体将寡核苷酸治疗剂高效、靶向递送至癌细胞的策略。
Int J Nanomedicine. 2025 Jun 23;20:8023-8039. doi: 10.2147/IJN.S519906. eCollection 2025.
2
Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics.用于靶向递送的脂质纳米颗粒的组成:在mRNA治疗中的应用。
Front Pharmacol. 2024 Oct 23;15:1466337. doi: 10.3389/fphar.2024.1466337. eCollection 2024.
3
Current landscape of mRNA technologies and delivery systems for new modality therapeutics.新型治疗模式的 mRNA 技术和递送系统的现状。
J Biomed Sci. 2024 Sep 10;31(1):89. doi: 10.1186/s12929-024-01080-z.
4
Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies.增强 RNA-脂质纳米颗粒的递送:组织和细胞特异性及条码策略。
J Control Release. 2024 Nov;375:366-388. doi: 10.1016/j.jconrel.2024.08.030. Epub 2024 Sep 18.
5
From structural design to delivery: mRNA therapeutics for cancer immunotherapy.从结构设计到递送:用于癌症免疫治疗的mRNA疗法
Exploration (Beijing). 2023 Nov 17;4(2):20210146. doi: 10.1002/EXP.20210146. eCollection 2024 Apr.
6
Delivery of nucleic acids using nanomaterials.使用纳米材料递送核酸。
Mol Biomed. 2023 Dec 14;4(1):48. doi: 10.1186/s43556-023-00160-0.
7
'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective.用于器官选择性全身递送的“被动”纳米颗粒:设计、机制和展望。
Chem Soc Rev. 2023 Oct 30;52(21):7579-7601. doi: 10.1039/d2cs00998f.
8
mRNA nanodelivery systems: targeting strategies and administration routes.信使核糖核酸纳米递送系统:靶向策略与给药途径
Biomater Res. 2023 Sep 22;27(1):90. doi: 10.1186/s40824-023-00425-3.
9
Targeting materials and strategies for RNA delivery.靶向 RNA 递送的材料和策略。
Theranostics. 2023 Aug 21;13(13):4667-4693. doi: 10.7150/thno.87316. eCollection 2023.
10
Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs.用于递送基因药物的被动、主动和内源性器官靶向脂质及聚合物纳米颗粒。
Nat Rev Mater. 2023;8(4):282-300. doi: 10.1038/s41578-022-00529-7. Epub 2023 Jan 19.

本文引用的文献

1
Strategies, design, and chemistry in siRNA delivery systems.siRNA 递药系统中的策略、设计与化学
Adv Drug Deliv Rev. 2019 Apr;144:133-147. doi: 10.1016/j.addr.2019.05.004. Epub 2019 May 15.
2
Branched-Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pH.分支尾状脂质纳米颗粒由于在内涵体 pH 下增强的离子化作用而在体内有效地传递 mRNA。
Small. 2019 Feb;15(6):e1805097. doi: 10.1002/smll.201805097. Epub 2019 Jan 13.
3
Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis.帕替拉韦,一种用于治疗遗传性转甲状腺素蛋白介导的淀粉样变性的RNA干扰疗法。
Neurodegener Dis Manag. 2019 Feb;9(1):5-23. doi: 10.2217/nmt-2018-0033. Epub 2018 Nov 27.
4
Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I.基于树状高分子的脂质纳米颗粒递送治疗性 FAH mRNA,以恢复肝功能并延长肝肾酪氨酸血症 I 型小鼠模型的生存时间。
Adv Mater. 2018 Dec;30(52):e1805308. doi: 10.1002/adma.201805308. Epub 2018 Oct 25.
5
Optimization of a Degradable Polymer-Lipid Nanoparticle for Potent Systemic Delivery of mRNA to the Lung Endothelium and Immune Cells.优化一种可降解聚合物-脂质纳米颗粒,以实现 mRNA 对肺内皮细胞和免疫细胞的高效系统递释。
Nano Lett. 2018 Oct 10;18(10):6449-6454. doi: 10.1021/acs.nanolett.8b02917. Epub 2018 Sep 20.
6
FDA approves second GPCR-targeted antibody.美国食品药品监督管理局批准第二种针对G蛋白偶联受体的抗体。
Nat Rev Drug Discov. 2018 Aug 30;17(9):613. doi: 10.1038/nrd.2018.153.
7
Customizable Lipid Nanoparticle Materials for the Delivery of siRNAs and mRNAs.可定制化脂质纳米颗粒材料用于 siRNA 和 mRNA 的递送。
Angew Chem Int Ed Engl. 2018 Oct 8;57(41):13582-13586. doi: 10.1002/anie.201809056. Epub 2018 Sep 14.
8
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA induces homology-directed DNA repair.纳米颗粒递送Cas9核糖核蛋白和供体DNA可诱导同源定向DNA修复。
Nat Biomed Eng. 2017;1:889-901. doi: 10.1038/s41551-017-0137-2. Epub 2017 Oct 2.
9
Rapid, Single-Cell Analysis and Discovery of Vectored mRNA Transfection In Vivo with a loxP-Flanked tdTomato Reporter Mouse.利用带有loxP侧翼tdTomato报告基因小鼠在体内进行快速单细胞分析及载体mRNA转染的发现
Mol Ther Nucleic Acids. 2018 Mar 2;10:55-63. doi: 10.1016/j.omtn.2017.11.005. Epub 2017 Nov 21.
10
A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation.数百种纳米颗粒介导的体外和体内核酸递呈的直接比较显示出弱相关性。
Nano Lett. 2018 Mar 14;18(3):2148-2157. doi: 10.1021/acs.nanolett.8b00432. Epub 2018 Mar 5.

用于将mRNA递送至肝脏的脂质修饰氨基糖苷类药物。

Lipid-Modified Aminoglycosides for mRNA Delivery to the Liver.

作者信息

Yu Xueliang, Liu Shuai, Cheng Qiang, Wei Tuo, Lee Sang, Zhang Di, Siegwart Daniel J

机构信息

Department of Biochemistry, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.

出版信息

Adv Healthc Mater. 2020 Apr;9(7):e1901487. doi: 10.1002/adhm.201901487. Epub 2020 Feb 28.

DOI:10.1002/adhm.201901487
PMID:32108440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8152636/
Abstract

Cationic lipid nanoparticles (LNPs) are widely used as carriers for delivery of nucleic acids. Most synthetic routes toward cationic lipids have derived from simple amine cores. Greater chemical diversity can be obtained through starting with natural products containing basic nitrogen atoms, which offers routes to more complex molecules. Natural building blocks are not extensively explored, such as aminoglycosides, which are both structurally and functionally interesting for developing new carriers for nucleic acid delivery. Herein, cationic lipid-modified aminoglycosides (CLAs) are explored as a family of vehicles for messenger RNA (mRNA) delivery. CLAs are synthesized from natural existing aminoglycosides coupling with alkyl epoxides and acrylates. The top hit (GT-EP10) is able to deliver Luc mRNA to C57BL/6 mice at a dose of 0.05 mg kg to achieve a 10 average luminescence intensity in the liver. The Lox-Stop-Lox tdTomato mouse model is used to further demonstrate that this efficient mRNA delivery system can be potentially used for gene editing. Successful delivery of human erythropoietin mRNA shows that CLA-based LNPs have promising opportunities for delivery of therapeutic nucleic acids in the future.

摘要

阳离子脂质纳米颗粒(LNPs)被广泛用作核酸递送载体。大多数合成阳离子脂质的路线都源自简单的胺核心。从含有碱性氮原子的天然产物开始可以获得更大的化学多样性,这为合成更复杂的分子提供了途径。天然构建模块尚未得到广泛探索,例如氨基糖苷类,其在开发新型核酸递送载体方面在结构和功能上都很有趣。在此,阳离子脂质修饰的氨基糖苷类(CLAs)被探索作为一类用于信使核糖核酸(mRNA)递送的载体。CLAs由天然存在的氨基糖苷类与烷基环氧化物和丙烯酸酯偶联合成。最佳的(GT-EP10)能够以0.05毫克/千克的剂量将荧光素酶mRNA递送至C57BL/6小鼠,在肝脏中实现平均发光强度为10。Lox-Stop-Lox tdTomato小鼠模型用于进一步证明这种高效的mRNA递送系统可潜在地用于基因编辑。成功递送人促红细胞生成素mRNA表明基于CLA的LNPs在未来递送治疗性核酸方面具有广阔前景。